Evidence map›Paper›PMID 29732032›Full record

ArticleCaspian journal of internal medicine2018

High -density lipoprotein cholesterol as a predictor for diabetes mellitus.

Hong Wu, Peng Ouyang, Wenjun Sun

Open access · greenAbstract read
In one paragraph

Article in Caspian journal of internal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hong WuSchool of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Peng OuyangSchool of Management, Harbin Institute of Technology, Harbin, China.
Wenjun SunSchool of Management, Harbin Institute of Technology, Harbin, China.
Harbin Institute of Technology · CNHuazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes is a prevalent chronic disease around the world. To evaluate the risk of diabetes comprehensively, we developed a score model for risk prediction with HDL-C as a protective factor.

methodsWe extracted physical examination data of 2728 individuals. The data contain 18 demographic and clinical variables. To identify the statistical significant feature variables, the backward stepwise logistic regression was used based on the data of the "exploratory population". To ascertain the cutoff value of the selected variables, we used the Youden index. Then we assigned each variable level a score according to the estimated regression model coefficients and then calculated the individual's total score. We gained the cutoff value for the total score through the Youden Index and stratified the total score into four levels. We employed the data of "validation population" to test the performance of the score model based on the area under the ROC curve.

resultsAge, LDL-C, HDL-C, BMI, family history of diabetes, diastolic blood pressure and TCHO were selected as statistically significant variables. The diabetes risk score range varied from 0 to 17. The risk level categorized by the total score was low, middle, high and extremely high, with a score range of 0-2, 3-7, 8-12 and 13-17, respectively.

conclusionsThe score model based on physical examination data is an efficient and valuable tool to evaluate and monitor the potential diabetes risk for both healthy and unhealthy people at an individual level.

Indexed as

DiabetesRisk scoreScore model

Identifiers

PMID29732032
PMCPMC5912222
OpenAlexW2783829252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.